MedTrace Logo

Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke

NCT01104467 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2021-08-31

No results posted yet for this study

Summary

The purpose of the study is to evaluate whether desmoteplase is safe and tolerated when given to Japanese patients with acute ischemic stroke

Conditions

  • Acute Ischemic Stroke

Interventions

DRUG

Desmoteplase

1 bolus injection of desmoteplase 70 µg/kg intravenous (IV)

DRUG

Desmoteplase

1 bolus injection of desmoteplase 90 µg/kg (IV)

OTHER

Placebo

1 bolus injection of placebo IV

Sponsors & Collaborators

  • Lundbeck Japan K. K.

    lead INDUSTRY

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01104467 on ClinicalTrials.gov